Side effects.

• Author: Peters, Charles
• Position: Tilting at Windmills - Brief Article

Another story in the Journal, this about the recent Vioxx recall, calls to mind a point this magazine made four years ago (Stephen Pomper's "Drug Rush," May 2000) about the limited resources the FDA devotes to "studying the safety of medical products after they're already approved." Most of the FDA's budget goes to the drug approval process, with little left for finding out about any harm the drugs do once they're in use. This, of course, reflects...